Azilsartan medoxomil

CAS No. 863031-21-4

Azilsartan medoxomil( TAK 491 | TAK-491 | TAK491 )

Catalog No. M16246 CAS No. 863031-21-4

A specific and potent angiotensin II type 1 receptor (AT1) antagonist with IC50 of 2.6 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 In Stock
5MG 72 In Stock
10MG 110 In Stock
25MG 200 In Stock
50MG 335 In Stock
100MG 494 In Stock
500MG 1053 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Azilsartan medoxomil
  • Note
    Research use only, not for human use.
  • Brief Description
    A specific and potent angiotensin II type 1 receptor (AT1) antagonist with IC50 of 2.6 nM.
  • Description
    A specific and potent angiotensin II type 1 receptor (AT1) antagonist with IC50 of 2.6 nM, used in the treatment of adults with essential hypertension. Hypertension Approved.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Rats Dosage:0.03-10 mg/kg Administration:oral gavage, once a day for 4 days Result:Reduced myocardial infarct size.Increased calcium-dependent nitric oxide synthase activity.Increased Akt, ERK 1/2 and eNOS phosphorylation and inhibited BAX activation.
  • Synonyms
    TAK 491 | TAK-491 | TAK491
  • Pathway
    GPCR/G Protein
  • Target
    Angiotensin Receptor
  • Recptor
    AT1receptor
  • Research Area
    Cardiovascular Disease
  • Indication
    Hypertension

Chemical Information

  • CAS Number
    863031-21-4
  • Formula Weight
    568.5336
  • Molecular Formula
    C30H24N4O8
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)OCC6=C(OC(=O)O6)C
  • Chemical Name
    1H-Benzimidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. French C, et al. J Cardiovasc Pharmacol. 2011 Aug;58(2):143-8. 2. Kusumoto K, et al. Eur J Pharmacol. 2011 Nov 1;669(1-3):84-93. 3. B?nner G, et al. J Hum Hypertens. 2013 Aug;27(8):479-86.
molnova catalog
related products
  • Olmesartan medoxomil

    An angiotensin II receptor antagonist which has been used for the treatment of high blood pressure.

  • Norleual

    Angiotensin IV analog. Highly potent HGF/c-MET inhibitor (IC50 = 3 pM). Inhibits HGF-induced MDCK cell proliferation and invasion in vitro. Also AT4 receptor antagonist; disrupts LTP stabilization. Antiangiogenic.

  • Azilsartan medoxomil...

    An orally administered angiotensin II receptor type 1 antagonist with IC50 of 0.62 nM.